Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hopkinson Craig C.
Relationship:   Director
City:   Waltham
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   120,204    

Indirect Shares

   0      
Direct Value   $3,174,264    

Indirect Value

   $0      
Total Shares   120,204      
Total Value   $3,174,264      


Alkermes Plc $2,710,909 Albireo Pharma Inc $463,354 Alkermes Plc $2,710,909 Albireo Pharma Inc $463,354
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alkermes Plc ALKS EVP R&D, Chief Medical... 2024-02-23 109,709 2018-06-07 0    Premium*  
            Albireo Pharma Inc ALBO Director 2022-12-01 10,495 2022-12-01 0    Premium*  
* Premium Members only  

Records found :    56         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALKS Alkermes Plc SVP, Med Dev/Med Affairs, CMO   •       •      –    2018-06-07 4 OE $0.00 $0 D/D 1,250 1,250 0 -
ALKS Alkermes Plc SVP, Med Dev/Med Affairs, CMO   •       •      –    2018-12-07 4 A $0.00 $0 D/D 4,000 4,881 0 -
ALKS Alkermes Plc SVP, Med Dev/Med Affairs, CMO   •       •      –    2019-02-16 4 OE $0.00 $0 D/D 3,375 7,078 0 -
ALKS Alkermes Plc SVP, Med Dev/Med Affairs, CMO   •       •      –    2019-06-07 4 OE $0.00 $0 D/D 1,250 7,245 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2020-02-16 4 OE $0.00 $0 D/D 3,375 10,252 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2020-02-21 4 OE $0.00 $0 D/D 6,875 15,955 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2020-06-07 4 OE $0.00 $0 D/D 1,250 15,201 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2021-02-16 4 OE $0.00 $0 D/D 3,375 18,208 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2021-02-20 4 OE $0.00 $0 D/D 10,095 27,131 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2021-02-21 4 OE $0.00 $0 D/D 6,875 30,942 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2021-06-07 4 OE $0.00 $0 D/D 1,250 1,250 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2021-09-14 4 A $0.00 $0 D/D 15,143 15,143 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2022-02-16 4 OE $0.00 $0 D/D 3,375 12,871 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2022-02-20 4 OE $0.00 $0 D/D 10,096 19,592 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2022-02-21 4 OE $0.00 $0 D/D 6,875 23,501 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2022-02-22 4 OE $0.00 $0 D/D 12,037 33,516 0 -
ALBO Albireo Pharma Inc Director   –       •      –    2022-12-01 4 A $0.00 $0 D/D 10,495 10,495 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2023-02-18 4 OE $0.00 $0 D/D 8,722 26,716 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2023-02-20 4 A $0.00 $0 D/D 22,195 52,570 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2023-02-20 4 OE $0.00 $0 D/D 10,095 34,155 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2023-02-21 4 OE $0.00 $0 D/D 6,875 52,919 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2023-02-22 4 OE $0.00 $0 D/D 12,038 61,904 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2024-02-08 4 A $0.00 $0 D/D 46,658 103,217 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2024-02-18 4 OE $0.00 $0 D/D 8,897 96,834 0 -
ALKS Alkermes Plc EVP R&D, Chief Medical Officer   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 10,297 103,180 0 -
  56  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us